(Q40455543)

20 September 2017

1 reference

title

Vaccine safety evaluation: Practical aspects in assessing benefits and risks. (English)

1 reference

20 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Alberta Di Pasquale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Nathalie Garçon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Lawrence R Stanberry

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Mostafa El-Hodhod

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Fernanda Tavares Da Silva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

8 November 2016

1 reference

20 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

6672-6680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

Understanding public perceptions of benefits and risks of childhood vaccinations in the United States

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Active surveillance for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Under-reporting of adverse drug reactions : a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Perspectives on the future of postmarket vaccine safety surveillance and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

The science of evaluation of adverse events associated with vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Algorithm to assess causality after individual adverse events following immunizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Comprehensive assessment of serious adverse events following immunization by health care providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

The Brighton Collaboration: enhancing comparability of vaccine safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

A comparison of active adverse event surveillance systems worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Acellular pertussis vaccines in Japan: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Contraindications to vaccination in the Russian Federation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

Vaccine development: From concept to early clinical testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.10.039

10.1016/J.VACCINE.2016.10.039

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27836435%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference